BROADWOOD PARTNERS, L.P. 4
4 · Insight Molecular Diagnostics Inc. · Filed Apr 27, 2026
Research Summary
AI-generated summary of this filing
IMDX — Broadwood Partners (10% Owner) Buys Stock
What Happened
Broadwood Partners, L.P. (reported as a 10% owner) made open-market purchases of Insight Molecular Diagnostics, Inc. (IMDX) common stock on April 23, 24 and 27, 2026. The filing shows 280,381 shares at $3.50 (≈$982,034) on Apr 23; 38,880 shares at $3.53 (≈$137,083) on Apr 24; and 250,923 shares at $3.64 (≈$913,134) on Apr 27 — a total of 570,184 shares purchased for approximately $2,032,251. These were purchases (P), which are generally interpreted as insider/owner buying shares rather than selling.
Key Details
- Transaction dates and reported prices:
- 2026-04-23: 280,381 shares @ $3.50 (≈ $982,034)
- 2026-04-24: 38,880 shares @ $3.53 (≈ $137,083)
- 2026-04-27: 250,923 shares @ $3.64 (≈ $913,134)
- Total shares acquired: 570,184; total cash spent: ≈ $2.03 million.
- Shares owned after transaction: Not specified in the provided summary of the filing.
- Notable footnotes:
- F1: Securities are directly owned by Broadwood Partners, L.P.; Broadwood Capital, Inc. (general partner) and Neal C. Bradsher (president of Broadwood Capital) may be deemed beneficial owners but disclaim beneficial ownership except for pecuniary interest.
- F3–F5: The filing reports weighted-average purchase prices and notes the actual per-share prices ranged across the trades (rough ranges reported: $3.39–$3.84); full per-price breakdown available on request to the SEC staff or issuer.
- F6: Mentions warrants are currently exercisable (not directly tied to the listed purchases).
- Filing date: Report filed with the SEC Apr 27, 2026, covering purchases made Apr 23–27, 2026. (Check the official Form 4 for any timeliness designation.)
Context
- This activity is by a 10% institutional owner (Broadwood Partners), not an individual company executive; such institutional purchases can reflect portfolio or investment decisions rather than executive-level trading signals.
- Purchases (code P) are generally more informative to retail investors than routine sales because they indicate capital deployed to accumulate stock; the filing provides weighted-average price ranges and offers more granular price details to regulators or holders on request.
Insider Transaction Report
Form 4
BROADWOOD PARTNERS, L.P.
10% Owner
Transactions
- Purchase
Common Stock, no par value
[F3][F1]2026-04-23$3.50/sh+280,381$982,034→ 12,395,081 total - Purchase
Common Stock, no par value
[F1]2026-04-23+0→ 12,395,081 total(indirect: Footnote) - Purchase
Common Stock, no par value
[F4][F1]2026-04-24$3.53/sh+38,880$137,083→ 12,433,961 total - Purchase
Common Stock, no par value
[F1]2026-04-24+0→ 12,433,961 total(indirect: Footnote) - Purchase
Common Stock, no par value
[F5][F1]2026-04-27$3.64/sh+250,923$913,134→ 12,684,884 total - Purchase
Common Stock, no par value
[F1]2026-04-27+0→ 12,684,884 total(indirect: Footnote)
Holdings
- 157
Common Stock, no par value
[F2] - 150,093
Warrant to Purchase Common Stock
[F6][F1]Exercise: $30.60Exp: 2027-04-19→ Common Stock (150,093 underlying) - 150,093(indirect: Footnote)
Warrant to Purchase Common Stock
[F6][F1]Exercise: $30.60Exp: 2027-04-19→ Common Stock (150,093 underlying)
Footnotes (6)
- [F1]The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be beneficially owned by each of: (i) Broadwood Capital, Inc. ("Broadwood Capital"), as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher, as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F2]These securities are directly owned by Neal C. Bradsher.
- [F3]This constitutes the weighted average purchase price. The prices range from $3.39 to $3.54. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F4]This constitutes the weighted average purchase price. The prices range from $3.47 to $3.59. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F5]This constitutes the weighted average purchase price. The prices range from $3.50 to $3.84. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F6]These warrants are currently exercisable.